3,324 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Monday’s Close
JNJ Johnson & Johnson $133.68 $358.65B Uptrend
Article Searches
Basic Guide To Successful Investing - Part I https://seekingalpha.com/article/4157375-basic-guide-successful-investing-part?source=feed_sector_healthcare Mar 18, 2018 - My approach to investing.Understanding Free Cash Flow and its importance.Letting compound interest do much of the work for you.
3 Things In Biotech, March 17: Janssen's Bladder Breakthrough, MorphoSys' Alzheimer's Success, Halozyme's Early Results https://seekingalpha.com/article/4157370-3-things-biotech-march-17-janssens-bladder-breakthrough-morphosys-alzheimers-success?source=feed_sector_healthcare Mar 18, 2018 - Janssen scores a breakthrough in bladder cancer.MorphoSys and Roche announce supporting evidence for their Alzheimer's study.Halozyme highlights preclinical studies at AACR.
Is Johnson & Johnson a Buy? https://www.fool.com/investing/2018/03/18/is-johnson-johnson-a-buy.aspx?source=iedfolrf0000001 Mar 18, 2018 - The case for -- and against -- the healthcare giant.
Johnson & Johnson: A Dividend King For Strong Returns https://seekingalpha.com/article/4157319-johnson-and-johnson-dividend-king-strong-returns?source=feed_sector_healthcare Mar 17, 2018 - Johnson & Johnson is a diversified, stable company.Johnson & Johnson has a solid growth outlook, thanks to a strong pharmaceutical pipeline, and industry tailwinds.Shares of Johnson & Johnson will lik
Analysts say divestiture of Johnson Controls power solutions business makes sense http://feeds.bizjournals.com/~r/industry_8/~3/mqbIqzubJ0U/analysts-say-divestiture-of-johnson-controls-power.html Mar 17, 2018 - Johnson Controls CEO George Oliver said in a Monday release that strategic analysis of the power solutions business was intended to maximize shareholder value. Several analysts viewed the decision positively in reports released this week.
Retire Rich: How To Buy Low And Sell High https://seekingalpha.com/article/4157300-retire-rich-buy-low-sell-high?source=feed_tag_editors_picks Mar 17, 2018 - We discuss if it is at all possible to buy low and sell high on a consistent basis.We discuss a conservative and systematic strategy to buy low and sell high using DGI stocks.The strategy provides nea
Jimmie Johnson plans to race on without Lowe's sponsorship http://www.startribune.com/business/477146703.html Mar 16, 2018 -
Vocations: A Pilot Who Has Broken 2 Glass Ceilings https://www.nytimes.com/2018/03/16/jobs/a-pilot-who-has-broken-2-glass-ceilings.html?partner=rss&emc=rss Mar 16, 2018 - Stephanie Johnson is the first black woman with the rank of captain at two major airlines, Northwest and Delta, her current employer.
Former Rams cornerback Trumaine Johnson signs five-year, $72-million contract with Jets http://www.latimes.com/la-sp-rams-trumaine-johnson-jets-20180316-story.html Mar 16, 2018 -

Cornerback Trumaine Johnson, who earned nearly $31 million the last two seasons while playing for the Rams, cashed in again Friday, signing a five-year, $72.5-million contract with the New York Jets.

Johnson is guaranteed $34 million, including a $20-million signing bonus, according to a published...

Coca-Cola: Dividend King But With Poor Total Return https://seekingalpha.com/article/4157061-coca-cola-dividend-king-poor-total-return?source=feed_all_articles Mar 16, 2018 - Coca-Cola Has increased its dividend for 55 years, a Dividend King and presently has a yield of 3.3% which is well above average.Coca-Cola three-year forward CAGR of 7% is good and will give you growt

Pages: 123456...333

Page 1>

Related Companies

Name Exchange Price Mkt Cap
TIG TiGenix NASDAQ $42.01 $248.76B
PFE Pfizer, Inc. NYSE $36.78 $218.95B
NVS Novartis AG NYSE $82.06 $190.17B
ABBV AbbVie Inc. NYSE $113.71 $180.57B
MRK Merck & Company, Inc. NYSE $55.67 $150.1B
Sector: Health Care > Industry: Major Pharmaceuticals
DeepLinks for Johnson & Johnson
JNJ - Google Finance https://www.google.com/finance?q=JNJ Industry related info and international coverage Summary News
JNJ - Bloomberg http://www.bloomberg.com/research/stocks/snapshot/snapshot.asp?ticker=JNJ Original news and commentary from Bloomberg Charts Financials with pensions Snapshot Earnings Transactions People Options